Home  >  Products  >  LHFPL4 (lipoma HMGIC fusion partner-like 4 ) Blocking Peptide (the C terminal of LHFPL4)(100ug)
LHFPL4 (lipoma HMGIC fusion partner-like 4 ) Blocking Peptide (the C terminal of LHFPL4)(100ug)

LHFPL4 (lipoma HMGIC fusion partner-like 4 ) Blocking Peptide (the C terminal of LHFPL4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LHFPL4 Antibody (ARP67643_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67643
Size: 100ug
Weight: 27kDa
Gene: 375323
Format: Lyophilized powder
Target: This gene is a member of the lipoma HMGIC fusion partner (LHFP) gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding genes. Mutations in one LHFP-like gene result in deafness in humans and mice, and a second LHFP-like gene is fused to a high-mobility group gene in a translocation-associated lipoma.
Alternative names: MGC133162
See Full Product Listings >